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ABSTRACT
The S. cerevisiae genome encodes two M16A enzymes: Axl1p and Ste23p. Of the two, Ste23p
shares significantly higher sequence identity with M16A enzymes from other species, including
mammalian insulin-degrading enzymes (IDEs). In this study, recombinant Ste23p and R.
norvegicus IDE (RnIDE) were isolated from E. coli, and their enzymatic properties compared.
Ste23p was found to cleave established RnIDE substrates including the amyloid-β peptide (Aβ 1-40)
and insulin B chain. A novel internally quenched fluorogenic substrate (Abz-SEKKDNYIIKGVnitroY-OH) based on the polypeptide sequence of the yeast P2 a-factor mating propheromone was
determined to be a suitable substrate for both Ste23p and RnIDE, and was used to conduct
comparative enzymological studies. Both enzymes were most active at 37 °C, in alkaline buffers,
and in high salt environments. In addition, the proteolytic activities of both enzymes towards the
fluorogenic substrate were inhibited by metal chelators, thiol modifiers, inhibitors of cysteine
protease activity, and insulin. Characteristics of STE23 expression were also evaluated. Our
analysis indicates that the 5´ terminus of the STE23 gene has been mischaracterized, with the
physiologically relevant initiator corresponding to residue M53 of the publicly annotated protein
sequence. Finally, we demonstrate that unlike haploid-specific Axl1p, Ste23p is expressed in both
haploid and diploid cell types. Our study presents the first comprehensive biochemical analysis of a
yeast M16A enzyme, and provides evidence that S. cerevisiae Ste23p has enzymatic properties that
are highly consistent with mammalian IDEs and other M16A enzymes.
INTRODUCTION
The M16A subfamily comprises a group of
large (~100 kDa), zinc-dependent metalloendopeptidases, which are found within all
prokaryotic and eukaryotic organisms that have
been thoroughly examined (Rawlings, 2008).
M16A enzymes are characterized by the presence
of an essential HxxEH motif generally located
within 200 residues of the amino terminus. These
residues are responsible for zinc coordination and

catalysis (Becker and Roth, 1992).
Structural characterization of M16A subfamily
enzymes has been reported (Im, et al., 2007;
Maskos, 2005; Shen, et al., 2006).
M16A
enzymes have quaternary structure that is similar
to a clamshell in appearance, with N- and Cterminal bowl-shaped domains of approximately
50 kDa connected by a short linker region of 2030 residues. Both the N- and C-terminal domains,
as well as individual residues from highly
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conserved sequences within each domain, are
required for the catalytic function of M16A
enzymes (Alper, et al., 2006; Becker and Roth,
1993; Ding, et al., 1992; Kim, et al., 2005; Li, et
al., 2006; Perlman, et al., 1993). Recent studies of
the human insulin-degrading enzyme (HsIDE) and
bacterial pitrilysin (EcPtr) have demonstrated that
M16A enzymes can adopt either an ‘open’
conformation, which is hypothesized to permit
substrate access to a central catalytic
compartment, or a ‘closed’ conformation, which is
presumed to be necessary for proteolysis, yet
likely prohibits entrance and exit of substrates
from the catalytic site (Maskos, 2005; Shen, et al.,
2006).
Transitions between the ‘open’ and
‘closed’ conformations of M16A enzymes are
hypothesized to represent a rate-limiting step
within these enzymes’ catalytic cycles. Consistent
with this hypothesis, mutations that disrupt
interactions between the N- and C-terminal
domains of HsIDE increase catalytic activity by as
much as 40-fold (presumably by facilitating the
transition between the open and closed
conformations of the enzyme) (Shen, et al., 2006).
Allosteric regulation of HsIDE and R. norvegicus
IDE (RnIDE) by ATP has been reported, although
the underlying reason for such regulation is not
understood at present (Camberos, 2001; Song, et
al., 2004).
Eukaryotic M16A enzymes also
demonstrate sensitivity to N-ethylmaleimide
(NEM) and other thiol modifiers, though the
mechanistic importance of cysteine residues
within these enzymes remains poorly elucidated
(Becker and Roth, 1995; Kim, et al., 2005; NeantFery, et al., 2008).
M16A enzymes have broad yet selective
substrate specificity. Established substrates of
M16A enzymes include insulin, amyloid beta (Aβ)
peptides, glucagon, amylin, plant systemin, and
yeast P2 pro-a-factor, among others (Adames, et
al., 1995; Alper, et al., 2006; Bennett, et al., 2000;
Huet, et al., 2008; Kim, et al., 2005; Kirschner and
Goldberg, 1983; Qiu, et al., 1998). Structural
studies of HsIDE in complex with multiple peptide
substrates have revealed several features that play
a role in substrate recognition by this and
presumably other M16A enzymes (Maskos, 2005;
Shen, et al., 2006). To be recognized by HsIDE,
potential substrates must be capable of anchoring
within the enzyme’s catalytic binding pocket and
forming favorable interactions with enzymatic β-

strands proximal to the site of peptide hydrolysis.
Potential substrates must also be small enough
(~50 amino acids in length) to permit
encapsulation within the central chamber of the
closed enzyme. Peptides with significant positive
charge at their C-terminus are generally poor
substrates due to unfavorable electrostatic
interactions with the positively charged face of the
central chamber contributed by the C-terminal
domain of the enzyme (Shen, et al., 2006). No
absolute primary sequence determinant has been
reported among substrates of the M16A subfamily.
However, studies of RnIDE using synthetic
fluorogenic peptides have shown that the enzyme
preferentially cleaves on the amino side of
hydrophobic and basic residues (Song, et al.,
2005), and studies of S. lycopersicum IDE (SlIDE)
using various alternative peptide substrates have
further suggested a limited preference for proline
one or two residues N-terminal to the site of
proteolytic cleavage (Huet, et al., 2008), which
may reflect an overall preference for substrates
that adopt a β-turn structure (Kurochkin, 1998).
Medical interest in the M16A subfamily has
been motivated in part by the proposal that HsIDE
serves a protective function in forestalling the
onset of Alzheimer’s disease (AD) (Hardy and
Selkoe, 2002; Selkoe, 2001). Human population
studies have indicated that variations in and
around the chromosomal locus encoding HsIDE
are risk factors for AD and Type II diabetes
mellitus (DM2) (Ertekin-Taner, et al., 2000;
Groves, et al., 2003; Kim, et al., 2007; Myers, et
al., 2000). Consistent with these observations,
IDE deficiency or loss of function in rodent
models has been correlated with increased levels
of Aβ and insulin, as well as increased incidence
of AD and DM2 (Farris, et al., 2003; Leissring, et
al., 2003; Miller, et al., 2003). Levels of soluble
and insoluble Aβ and premature death rates are
also significantly reduced in transgenic rodent
models in which both IDE and the amyloid
precursor protein, APP, have been overexpressed
(Leissring, et al., 2003).
Ste23p and Axl1p are the M16A enzymes
native to S. cerevisiae. Genetic studies support
involvement of Ste23p and Axl1p in exacting an
N-terminal endoproteolytic cleavage of the P2
precursor of the a-factor mating pheromone that is
produced by MATa haploid cells. MATa yeast that
lack functional copies of both Ste23p and Axl1p
2
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cannot signal mating competency to cells of the
complementary mating type and thus exhibit a
‘sterile’ mating phenotype (Adames, et al., 1995).
Axl1p expression is restricted to haploid yeast
(Fujita, et al., 1994), where, in addition to its role
in a-factor processing, the enzyme has several
other known functions.
These include
maintenance of a haploid-specific axial budding
pattern (Adames, et al., 1995; Fujita, et al., 1994),
repression of haploid-specific invasive growth
(Cullen and Sprague, 2002; Palecek, et al., 2000),
and promotion of efficient haploid cell fusion
during mating (Elia and Marsh, 1996). As
documented in this study, and by contrast to the
haploid-specific expression of Axl1p, Ste23p is
expressed in both haploid and diploid yeast.
Despite its broad expression profile, the only
known function of Ste23p is in a-factor
processing, a MATa-specific event. Its role in
MATα and diploid cells, which may also be
conserved in MATa cells, remains enigmatic.
Ste23p and Axl1p are not functionally equivalent
in terms of their ability to promote mature a-factor
production. Ste23p is responsible for at most 5%
of all a-factor production, yet it is expressed at
steady state levels that are at least ten times higher
than that observed for Axl1p (Adames, et al.,
1995; Alper, et al., 2006). These observations
suggest an alternative biological function of
Ste23p that has yet to be identified.
We now report a comparative biochemical
analysis of yeast Ste23p and RnIDE.
We
demonstrate that Ste23p exhibits conserved
specificity towards established RnIDE substrates
Aβ 1-40 and insulin B chain, and has enzymatic
characteristics that are similar to those of RnIDE
and other eukaryotic M16A enzymes. In addition,
we provide genetic and biochemical evidence that
the 5´ terminus of the STE23 ORF has been
mischaracterized. This study presents the first
detailed biochemical analysis of a fungal M16A
enzyme, and supports the suitability of Ste23p as a
model for continuing studies of the M16A
subfamily within S. cerevisiae.

2007; Wilbur and Lipman, 1983). Polypeptide
sequences for HsIDE, RnIDE, Drosophila
melanogaster IDE (DmIDE), SlIDE and EcPtr are
equivalent to the UniProtKB/Swiss-Prot protein
sequence entries P14735, P35559, P22817,
Q93YG9, and P05458, respectively (Leinonen, et
al., 2004).
The polypeptide sequence for
Caenorhabditis elegans IDE (CeIDE) corresponds
to WormBase protein entry WP:CE37861 (Bieri,
et al., 2007; Stein, et al., 2001). Polypeptide
sequences for Ste23p and Axl1p correspond to the
Ste23p and Axl1p protein sequences annotated
within the Saccharomyces Genome Database
(Cherry, et al., 1998). The polypeptide sequence
for Ustilago maydis Ste23p (UmSte23p) was
inferred from U. maydis genomic locus
UM03257.1 (Harvard, 2008), and the polypeptide
sequence for Schizosaccharomyces pombe
(SpSte23p) was inferred from S. pombe genomic
locus NP_593966 (Wood, et al., 2002). Graphical
representation of the Ste23p and RnIDE alignment
was created using BOXSHADE 3.21.
Yeast strains and plasmids- The yeast strains
and plasmids used in this study are listed in Tables
1 and 2, respectively. Yeast strains were grown at
30 °C in solid or liquid rich media (YEPD) or
synthetic complete (SC) dropout medium.
Plasmids p80, pRS316, pWS371, pWS375,
pWS482, pWS512 and pWS514 have been
previously described (Adames, et al., 1995; Kim,
et al., 2005; Sikorski and Hieter, 1989). Plasmids
having 5´ sequence deletions (pWS759-763) were
created by direct subcloning of PCR products
derived from pWS375, which were designed to
lack the appropriate DNA region and contain KpnI
and HindIII restriction sites that were subsequently
used to insert the PCR product into corresponding
sites of pWS482; the KpnI site is within the
pWS482 polylinker, and HindIII is internal to the
STE23 ORF. A plasmid lacking 5´ sequence and
the first predicted 156 nucleotides of STE23
(pWS765) was created in a similar manner.
pWS908
and
pWS909
were
obtained
commercially (Norclone Biotech Laboratories,
London, Ontario). Yeast transformations were
carried out according to established methods
(Elble, 1992).
Bacterial strains and plasmids- Bacterial
strains and plasmids used within this study are
included in Tables 1 and 2. DH5α E. coli
(Invitrogen Inc., San Diego, CA) was used for

MATERIALS AND METHODS
Sequence comparisons- Polypeptide sequences
of M16A enzymes from several commonly studied
organisms were evaluated using the multiple
global sequence alignment function of Clustal W
2.0.10 with default parameters (Larkin, et al.,
3
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amplification of plasmid DNA, and BL21(DE3) E.
coli (Novagen Inc., Darmstadt, Germany) was
used for protein expression.
pET30-b(+)
(Novagen Inc.) was used as the vector for
recombinant expression of Ste23p and RnIDE.
Bacterial cells were prepared for chemical
transformation according to established methods
(Hanahan, 1983).
Vectors for recombinant expression of STE23
and RnIDE were created within pET30-b(+) such
that each encoded an N-terminal polyhistidine tag
immediately behind a start codon. pWS769
(6xHis-Ste23pM53-E1027) was created by subcloning
a PCR fragment encoding the region of the STE23
gene corresponding with residues M53-E1027 of
the annotated Ste23p polypeptide sequence. This
sequence was amplified from pWS375 such that
an NdeI site, an ATG codon, and sequence
encoding a 6xHis tag were created at the 5´ end of
the fragment and a NotI site was created at the 3´
end. This strategy permitted direct subcloning into
corresponding sites within the pET-30b(+) vector.
Construction of pWS804 (6xHis-RnIDEM42-L1019)
was achieved in an analogous fashion and has
been described (Alper and Schmidt, 2009). DNA
sequencing analysis revealed two mutations
encoding single-site amino acid substitutions
Y248C and E768A within the plasmid encoding
RnIDE. The corresponding native residues are not
conserved between RnIDE and Ste23p, and are
positioned distal to the catalytic site as inferred
from analogous residues within HsIDE, the most
closely related RnIDE homolog for which
structural data is available.
Enzyme purification- 6xHis-Ste23pM53-E1027
and 6xHis-IDEM42-L1019 were expressed within
BL21 (DE3) E. coli and purified by immobilized
nickel affinity chromatography according to our
established methods (Alper and Schmidt, 2009).
In brief, a clarified cell lysate containing the
protein of interest was applied onto a HisTrap™
Fast Flow 5 mL column that was attached to an
AKTAprime™ FPLC system (GE Healthcare Inc.,
Piscathaway, NJ). Block elution with 0.5 M
imidazole was used to recover the bound protein
after washes to remove unbound material. The
imidazole concentration in the eluted sample was
reduced by first concentrating the sample to
approximately 1 mL using an Amicon Ultra™-15
mL 100 kDa MW-cutoff centrifugal filter device
(Millipore Inc., Bedford MA), and then diluting

the sample approximately 10-fold with Lysis
Buffer (50 mM HEPES, 140 mM NaCl, pH 7.4).
The dilution and concentration steps were repeated
once more prior to diluting the final sample to 1
mg/mL in Storage Buffer (Lysis Buffer containing
20% glycerol (v/v)). Molarities of the purified
enzymes were determined prior to dilution from
UV absorbance measurements and A280 extinction
coefficients according to established methods (Gill
and von Hippel, 1989). These values were
consistent with those determined by Bradford
assay. Sample aliquots were stored at -80 °C and
thawed as needed.
Peptides and reagents- Recombinant human
Aβ 1-40 (rPeptide Inc., Athens, GA), human
insulin, and insulin B chain (Sigma-Aldrich Inc.,
St. Louis, MO) and the quenched fluorogenic AbzSEKKDNYIIKGV-nitroY-OH peptide (AnaSpec
Inc., San Jose, CA) were all reconstituted from dry
powders. Detailed preparation of Aβ 1-40 and
insulin solutions has been reported elsewhere
(Alper and Schmidt, 2009). In brief, Aβ 1-40 was
treated with hexafluoroisopropanol (HFIP) to
ensure the initial monomeric state of the peptide
(Dahlgren, et al., 2002), and dissolved within
dimethylsulfoxide
(DMSO)
to
a
final
concentration of 4 mg/mL.
Insulin was
resuspended in DMSO to 4 mg/mL and sonicated
using a bath sonicator (Branson Inc., Danbury,
CT) for approximately 5 min to fully dissolve the
peptide. Insulin B chain was resuspended in
DMSO to a final concentration of 4 mg/mL, but
did not require sonication for complete solubility.
The Abz-SEKKDNYIIKGV-nitroY-OH peptide
was resuspended directly within DMSO to a final
concentration of 10 mM. After reconstitution, all
peptide-containing solutions were stored at -80 °C.
Ethylenediaminetetraacetic acid (EDTA), Nethylmaleimide (NEM), free cysteine, βmercaptoethanol (β-ME), dithiothreitol (DTT),
adenosine-5´-triphosphate (ATP), and guanosine
triphosphate (GTP) were prepared as 10 mM
stocks in deionized water. N,N,N´-tetrakis(2pyridylmethyl)ethylenediamine (TPEN), 1,10phenanthroline (1,10-P.), 4,7-phenanthroline (4,7P.), and phenylmethylsulphonyl fluoride (PMSF)
were prepared as 50 mM stocks in DMSO.
Capillary electrophoresis- Aβ 1-40 and insulin
B chain proteolysis were analyzed by capillary
electrophoresis (CE) as previously described
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(Alper and Schmidt, 2009). In brief, proteolytic
reactions (40 µL) were conducted in CE
Proteolysis Buffer (10 mM potassium phosphate,
pH 7.6) at 30 °C (Ste23p) or at 37 °C (RnIDE)
using 20 nM enzyme and an initial substrate
concentration of 0.1 mg/mL (Aβ 1-40 and insulin
B chain). Enzyme and substrate mixes were
independently prepared as 2x reaction premixtures by dilution within CE Proteolysis Buffer
that was warmed at 30 °C or 37 °C for 10 min,
prior to mixing the pre-mixtures within a prewarmed PCR tube to initiate the proteolytic
reaction.
Proteolysis was terminated after
appropriate intervals by heating the reaction
mixture to 80 °C for 3 min. Samples were then
stored at -80 °C prior to analysis.
Fluorescence assay- An internally quenched
fluorogenic dodecapeptide substrate centered on
the M16A proteolytic cleavage site within the
yeast P2 a-factor mating propheromone (AbzSEKKDNYIIKGV-nitroY-OH) was used to
monitor the activity of 6xHis-Ste23pM53-E1027 and
6xHis-IDEM42-L1019 under steady-state reaction
conditions. This substrate contains a fluorescent
aminobenzoic acid moiety (Abz) that is linked
through the peptide backbone to a nitrotyrosine
(nitroY) fluorescence quencher.
Proteolytic
cleavage results in enhanced sample fluorescence,
which can be quantified using a fluorimeter.
Effects of various environmental conditions
upon the enzymatic activities of Ste23p and
RnIDE were evaluated by manipulating a
component condition of the fluorescence assay
reaction mixture while holding all others constant.
The standard conditions for assays containing
Ste23p (20 nM) were 100 mM potassium
phosphate, pH 8.1 and 30 °C; the standard
conditions for RnIDE (50 nM) were 100 mM
potassium phosphate, pH 9.2, and 37 °C.
Potassium phosphate buffers were prepared
according to published methods (Gomori, 1956).
In general, the use of phosphate buffers was found
to permit maximal enzymatic activity relative to
alternative buffering systems (Alper, Rowse, and
Schmidt, unpublished observations). The initial
Abz-SEKKDNYIIKGV-nitroY-OH
peptide
concentration was 17 µM. Kinetic parameters
were determined using the standard conditions
described
above
and
initial
substrate
concentrations ranging from 3 – 172 µM.

Typical assembly of the reaction mixture
involved 1:1 mixing of appropriately diluted
substrate and enzyme solutions within an
individual well of a pre-warmed, black, flatbottomed fluorescence microtiter plate.
The
fluorogenic substrate was prepared as a 2x
reaction pre-mixture by dilution with appropriate
buffer in a PCR tube, and pre-equilibrated for 10
min at the desired temperature. Ste23p and RnIDE
were similarly prepared.
Where noted, premixtures contained competing substrate (0.16
mg/mL insulin) or added compounds (2 mM), the
latter preincubated with the enzyme for 10 min.
Proteolysis was initiated by combining the 2x premixtures. The total reaction volume of a typical
assay was 100 µL, except in the instance of
experiments involving Km determination, where
the total volume was 30 µL in an effort to permit
conservation of substrate. Larger volume samples
were combined in a 96-well microtiter plate;
smaller volumes were combined in a 384-well
plate. Sample fluorescence was analyzed at 420
nm over multiple time points over a 60 min time
course using a Bio-Tek® Synergy™ HT
fluorimeter equipped with a 320/420 nm
excitation/emission
filter
set
(Bio-Tek®
Instruments, Inc., Winooski, VT).
As controls for the fluorescence assay,
background and maximum fluorescence signals
were determined as reference points for all
conditions evaluated.
This analysis was
performed to identify reaction conditions that
modulated fluorescence of the reporter. The
background fluorescence signal was determined in
the absence of added enzyme, while retaining all
other components of the experimental reaction
mixture described above.
The maximum
fluorescence signal was determined in the
presence of trypsin (5 µg/mL), which cleaves the
Abz-SEKKDNYIIKGV-nitroY-OH
substrate,
after the proteolytic reaction was allowed to
proceed to completion.
In instances where
fluorescence was affected (e.g. altered pH, certain
added compounds), the absolute difference
between the negative and positive controls was
used as a normalization factor to calculate the
relative fluorescence output of the sample. Rate
values observed in the presence of added
compounds are reported relative to those for the
untreated enzymes.
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Rate Calculations- Data obtained by
fluorescence assay was analyzed using Microsoft
Excel™ and GraphPad Prism™ 4.0 Software.
Reaction velocity was determined from 10 to 30
min after the initiation of each experiment, or up
to such time as a maximum of 10% substrate
proteolysis was achieved, allowing for an initial
lag period upon mixing of enzyme and substrate
pre-mixtures.
Reported values represent the
average of least 3 experimental replicates each
derived from 10 experimental data points
satisfying the conditions described above.
Maximal reaction velocity and initial reaction
velocity were taken to be equivalent for purposes
of this analysis. Kinetic parameters for Ste23p
and RnIDE were determined using nonlinear
regression curve-fitting software within Prism™
and a 4-parameter logistic equation without
constraints.
Because significant intermolecular quenching
effects were observed with the fluorescence-based
substrate at concentrations >23 µM, activities
observed at these concentrations were adjusted by
correction factors for the purposes of kinetic
analysis.
These factors were concentrationdependent and derived by comparing best-fit
equations for both free Abz and a 1:1 mixture of
Abz and nitroY over a range of concentrations.
Free Abz data points were best fit by a 2nd order
polynomial function (R2 = 0.9998), whereas data
for the Abz and nitroY mixture was best fit by a 4parameter
logistic
equation
(R2=1.000).
Correction factors were determined from ratios of
fluorescence (i.e. RFUAbz/RFUAbz+nitroY) at specific
concentrations, which were multiplied against the
activities observed at those concentrations. The
correction factors were minor (0.98 to 1.05)
between 0-23 µM and progressively increased
(1.09 to 1.51) over the range of 34-172 µM.
Similar mathematical corrections have been
reported for other datasets where intermolecular
quenching has been observed (Lazure, et al.,
1998).
Yeast mating assay- Mating tests were
performed essentially as previously described
(Alper, et al., 2006; Kim, et al., 2005). In brief,
MATa yeast of the indicated genotypes were
cultured to saturation in selective (SC-ura) liquid
media while the MATα mating tester (IH1783;
MATα lys1) was cultured in YEPD. The saturated
cultures were then diluted with fresh media to

achieve a cell culture density of 0.95-1.05 OD600.
The diluted MATα cell suspension (98 µL) and an
appropriate MATa suspension (2 µL) were mixed,
and the mixed suspension spotted (5 µL) onto
synthetic defined (SD) solid media. Mating was
recorded after incubation at 30 °C for 48-72 hours.
An equivalent portion of the mixed suspension
was also spotted on SC-lys solid media to serve as
a loading control for MATa cell input.
Preparation
of
cell
extracts
and
immunoblotting- Yeast total cellular protein
extracts were prepared as previously described
(Fujimura-Kamada, et al., 1997). In brief, mid-log
cells (2 mL of 1.0 OD600 culture) were harvested
by centrifugation, rinsed with deionized water,
resuspended in 1 mL of cold deionized water, and
treated with a mixture of NaOH (0.24 N final) and
β-mercaptoethanol (0.14 M final) for 15 min while
on ice. Proteins were precipitated by addition of
TCA (11.5% final), recovered by centrifugation
(16,000 g x 15 min), resuspended in 50 µL of
prewarmed (~100 °C) urea sample buffer (250
mM Tris, pH 8.0, 6 M urea, 4% SDS, and 0.01%
bromophenol blue), and boiled for 3 min. Samples
were subjected to SDS-PAGE using a 10%
polyacrylamide gel. Immunoblot analysis was
performed using anti-HA (Roche, Ltd., Basel,
Switzerland) or anti-Act1p primary antibodies
(gift of R. Meager, University of Georgia, Athens,
GA), and appropriate HRP-conjugated secondary
antibodies (GE Health, Inc.). Visualization was
achieved by chemiluminescent detection methods
(BM Chemiluminescence Blotting Substrate,
Roche, Ltd.) according to the manufacturer’s
instructions.
RESULTS
Ste23p is the most highly conserved M16A
enzyme within S. cerevisiae. Two M16A enzymes
are encoded within the S. cerevisiae genome:
Ste23p and Axl1p. Primary sequence alignments
reveal that Ste23p shares a higher degree of amino
acid sequence identity with mammalian IDEs than
does Axl1p (35% vs. 18% identity to HsIDE,
respectively; Table 3). Moreover, Ste23p shares
roughly equal sequence conservation to
mammalian IDEs as is shared by other fungal
M16A enzymes, and has higher identity than
Axl1p when compared to IDE orthologs from
other species. Observations from prior studies
further indicate that Ste23p is the most
6
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representative IDE ortholog in S. cerevisiae, with
Axl1p likely having evolved to serve multiple
functions that are specific to this organism (see
Discussion). Hence, Ste23p was chosen as the
model yeast M16A enzyme for purposes of the
current analysis. A primary sequence alignment of
Ste23p and RnIDE reveals notable features of the
two enzymes, including conserved residues of the
characteristic M16A motif (Fig. 1).
Purification of Ste23p and RnIDE. 6xHisSte23pM53-E1027 and 6xHis-RnIDEM42-L1019 were
isolated primarily as single protein species of the
expected molecular mass (Fig. 2). The purified
proteins retain N-terminal polyhistidine tags, as
evidenced by immunoblot analysis using an anti6xHis antibody (Alper, Rowse, and Schmidt,
unpublished observations).
Ste23p and RnIDE are annotated in public
sequence databases as polypeptides having length
of 1027 and 1019 amino acids, respectively
(Cherry, et al., 1998; Leinonen, et al., 2004).
Relative to the annotated Ste23p and RnIDE
sequences, N-terminally truncated forms of these
enzymes were isolated for purposes of our
analysis. Our purification of ‘truncated’ enzymes
− beginning, in each case, at the first in-frame
methionine encoded downstream from the
annotated
initiator
−
over
‘full-length’
polypeptides was motivated by several factors.
First, HsIDE was recently purified and crystallized
as a similarly truncated protein (Shen, et al.,
2006), and to our knowledge, there has not been
definitive assignment of the initiator methionine
for any mammalian IDE (Baumeister, et al., 1993).
Second, attempts to purify the full annotated
sequence of Ste23p as a C-terminal polyhistidine
fusion protein led to a purification product having
T54 at its N-terminus, as determined by Edmund
degradation analysis (Alper, Rowse, and Schmidt,
unpublished observations); M53 was presumably
absent due to the action of methionine
aminopeptidase. Third, the ‘truncated’ form of
Ste23p most likely represents the physiologically
relevant form of the enzyme, as supported by data
presented elsewhere within this study (see Fig. 6).
Ste23p proteolyzes mammalian IDE substrates
Aβ 1-40 and insulin B chain. Ste23p has no
recognized physiological substrates other than the
yeast P2 a-factor; however, the fungal enzyme is
capable of proteolyzing the established
mammalian IDE substrates Aβ 1-40 and insulin B

chain (Fig. 3). Aβ 1-40 and insulin B chain are
common substrates of the M16A subfamily.
These peptides have been used to study the
proteolytic specificity of M16A enzymes even in
instances where they are unlikely biological
targets (Becker and Roth, 1992; Ding, et al., 1992;
Huet, et al., 2008). Analysis of samples from
time-course proteolysis experiments shows the
accumulation of multiple peaks that presumably
correspond with Aβ 1-40 and insulin B chain
degradation products, indicating that Ste23p
proteolyzes each of these substrates at multiple
sites (Figs. 3B-C).
These products are not
observed in the presence of histidine-tagged
glutathione S-transferase (GST-6xHis) under
otherwise similar reaction conditions (Alper,
Rowse, and Schmidt, unpublished observations),
indicating that proteolysis is not attributable to a
contaminating copurification product from the
bacterial lysate. Detectable accumulation of Aβ 140 and insulin B chain cleavage products is
apparent at the 1 hr and 4 hr timepoints,
respectively, suggesting that degradation of Aβ 140 occurs relatively more rapidly. For both
substrates, Ste23p-mediated product formation
appears slower than that mediated by RnIDE,
which cleaves Aβ 1-40 and insulin B chain to near
completion within 4 hrs (Figs. 3D-E). The identity
of Aβ 1-40 and insulin B chain degradation
products was not determined during this study.
However, RnIDE is known to proteolyze both
peptides at multiple cleavage sites, which have
been previously evaluated (Duckworth, et al.,
1998; McDermott and Gibson, 1997; Mukherjee,
et al., 2000).
Comparative activity studies. The enzymatic
properties of Ste23p and RnIDE were compared
using a continuous readout fluorescence assay
under conditions of varying pH, salt concentration,
temperature, and substrate concentration (Fig. 4).
Both enzymes were most active within alkaline
environments (Figs. 4A-B), with Ste23p having a
maximal activity of 0.49 ± 0.031 µmols x mg-1 x
min-1 at pH 8.1, and RnIDE having maximal
activity of 0.22 ± 0.004 µmols x mg-1 x min-1 at
pH 9.2, the most alkaline condition evaluated.
These values may be compared with the reported
values for RnIDE-mediated proteolysis of a
distinct synthetic fluorogenic Abz-GGFLRKGVQEDDnp peptide, which exhibits a Vmax of ~0.2
µmols x min-1 x mg-1, and RnIDE-mediated
7
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cleavage of β–endorphin, which exhibits a Vmax of
2.6 µmols x min-1 x mg-1, albeit under different
assay conditions (Song, et al., 2001). Both
enzymes displayed enhanced enzymatic activity at
high salt concentrations, with Ste23p and RnIDE
activities being stimulated 2- and 6-fold,
respectively, at the highest concentration of
potassium chloride evaluated (Figs. 4C-D). Both
enzymes displayed optimal activity at or about 37
°C (Figs. 4E-F). Kinetic parameters for Ste23p
and RnIDE were determined, revealing that both
had roughly equivalent affinity for the AbzSEKKDNYIIKGV-nitroY-OH peptide under the
conditions evaluated (Figs. 4G-H). Observed Km
values were 215 ± 69 µM and 219 ± 22 µM for
Ste23p and RnIDE, respectively.
Negligible
activity was observed by fluorescence assay using
a GST-6xHis control (Alper, Rowse, and Schmidt,
unpublished observations).
Given the otherwise similar enzymatic
properties of Ste23p and RnIDE identified within
our studies, we sought to determine whether the
two enzymes exhibited comparable sensitivity to
known modulators of M16A peptidase activity,
including metal chelators, thiol modifiers, and
certain inhibitors of cysteine protease activity.
This analysis, which was conducted using the
fluorescence assay, demonstrated that the
sensitivities of Ste23p generally paralleled that
observed for RnIDE (Fig. 5). Addition of EDTA,
TPEN, and 1,10-phenanthroline, as well as NEM,
free cysteine, and DTT resulted in substantial
inhibition of both Ste23p and RnIDE proteolysis
(<40% activity).
By comparison, the nonchelating agent 4,7-phenanthroline had limited
impact (>60% activity), and addition of βmercaptoethanol had little or no effect on both
enzymes (>80% activity). The serine protease
inhibitor PMSF and physiological cofactors ATP
and GTP also had limited impact on the activity of
both enzymes (>60% activity). Addition of the
competing substrate insulin to the proteolytic
reaction mixture substantially inhibited both
enzymes (<40% activity), but had a more
pronounced affect on RnIDE.
The predicted initiator methionine of Ste23p is
dispensable for activity in vivo. Our biochemical
analysis revealed that the extreme N-terminus
(residues 1-52) of the publicly annotated Ste23p
polypeptide sequence is not essential for catalytic

function in vitro.
To better understand the
significance of this region in vivo, genetic and
biochemical methods were used to assess its
importance for expression of functional Ste23p
(Fig. 6).
Our standard vector for Ste23p
expression contains approximately 1.5 kb of
genomic sequence 5´ of the STE23 ORF, inclusive
of a distinct ORF of opposite orientation that is
separated from STE23 by a 405 basepair intergenic
region (Fig. 6A). A modified version of this
expression vector that eliminated the entire
upstream sequence relative to the 5´ margin of the
STE23 ORF (∆-1467 → -1) supported functional
Ste23p expression as well as the unmodified
plasmid (Figs. 6B-C); the reduced mating
observed relative to WT is due to the absence of
AXL1 in the test strain. Loss of additional
nucleotide sequence (∆-1467 → +156),
specifically that encoding the annotated initiator
codon (M1) and genomic sequence up to but not
including the next available methionine codon
(M53), abolished Ste23p expression and function,
suggesting that the genetic region +1 → +156 of
STE23 is important for gene expression.
We next evaluated the dependence of Ste23p
expression on M1 and M53 codons by site directed
mutagenesis (Fig. 6D).
Mating and protein
expression were observed with the M1A mutant,
but not with the M53A mutant, implying that M53,
but not M1, is necessary for expression of
functional Ste23p.
Ste23p is expressed in both haploid and
diploid cell types. Whereas expression of the
yeast M16A homolog Axl1p is specific to haploid
cells (Fig. 7A) (Fujita, et al., 1994), the expression
pattern of Ste23p has not been previously reported.
In view of the widespread occurrence of IDE
across species and the broad tissue expression of
M16A enzymes within multi-cellular organisms
(Baumeister, et al., 1993), we hypothesized that
Ste23p would be expressed in an unrestricted
manner among the three cell types of S. cerevisiae
– diploid, MATa and MATα haploid. Indeed, our
analysis indicates that Ste23p is expressed in both
diploid and haploid cell types (Fig. 7B).
Moreover, Ste23p expression levels appear
relatively constant within each of the cell types
evaluated. Ste23p is produced at levels that are
approximately 10-fold higher than Axl1p, as
judged by immunoblots of serially diluted samples
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(Alper, et al., 2006). We interpret the unrestricted
expression of Ste23p and its high level of
production relative to Axl1p as potential indicators
of an as yet undetermined function for Ste23p that
is distinct from the enzyme’s role in P2 a-factor
processing. This function must be nonessential, as
yeast deficient for STE23 and/or AXL1 are viable.

observations led us to develop a fluorogenic
substrate
(Abz-SEKKDNYIIKGV-nitroY-OH)
based on the amino acid sequence of P2 a-factor,
but lacking the farnesyl moiety of the native
mating propheromone. This substrate provides a
useful tool for cross-species enzymological studies
of the M16A subfamily.
Using a continuous fluorescence assay to
measure Ste23p and RnIDE-mediated proteolysis
of the Abz-SEKKDNYIIKGV-nitroY-OH peptide,
we have demonstrated that in addition to
exhibiting reciprocal substrate specificity, Ste23p
and RnIDE have similar activity profiles in
response to alterations in pH, salt concentration,
and temperature (Fig. 4), and various agents that
are known modulators of M16A activity (Fig. 5).
M16A enzymes are recognized as Zn2+
metallopeptidases (Becker and Roth, 1992; Ding,
et al., 1992; Ebrahim, et al., 1991; Huet, et al.,
2008). Consistent with expectations, Ste23p and
RnIDE were both inhibited by certain metal
chelating agents. Also, like RnIDE and other
eukaryotic M16A enzymes, but unlike bacterial
EcPtr, Ste23p was inhibited by certain thiol
modifiers (Affholter, et al., 1990; Becker and
Roth, 1992; Ding, et al., 1992; Huet, et al., 2008;
Kuo, et al., 1990). Neither Ste23p nor RnIDE was
sensitive to ATP or GTP addition under conditions
of our analysis.
This observation may be
interpreted in the context of reports that
alternatively claim activation or inhibition of
mammalian IDE by these cofactors (Camberos,
2001; Huet, et al., 2008; Song, et al., 2004).
Ste23p also exhibits a broad pH profile, having
optimal activity over the range of pH 7.6 – 9.2.
Like RnIDE, the yeast enzyme was found to be
most active under alkaline conditions. We
speculate that basic environments may enhance the
propensity of M16A substrates to adopt a β-turn
structure, which could enhance their interaction
with catalytic residues in the N-terminal substrate
binding pockets of Ste23p or RnIDE, or
alternatively, that rate-limiting conformational
dynamics within the M16A enzymes themselves
are somehow altered under alkaline conditions.
The broad pH profile exhibited by Ste23p is not
without precedent.
Members of the M4
metallopeptidase subfamily (e.g. thermolysin) also
exhibit a broad pH profile and are optimally active
at alkaline pH (pH 7.0 – 8.5; Feder and Schuck,
2004). We speculate that the broad range pH

DISCUSSION
The M16A subfamily is emerging as a
remarkable class of enzymes, most notably due to
the proposed role of human IDE in protecting
against Alzheimer’s disease and the unusual
mechanism by which M16A enzymes capture and
cleave their substrates (Selkoe, 2001; Shen, et al.,
2006). Despite their widespread species
distribution, biological functions of M16A
enzymes remain poorly elucidated. Studies of
M16A enzymes within well-characterized models
may thus serve to distinguish functions of the
M16A subfamily that have yet to be identified. In
this study, we provide evidence that such studies
in yeast should focus on Ste23p, rather than
Axl1p. This conclusion is based on the higher
degree of amino acid sequence conservation that is
shared between Ste23p and other M16A enzymes
and the remarkably similar biochemical properties
of Ste23p and RnIDE.
To our knowledge, this study presents the first
biochemical characterization of a fungal M16A
enzyme. We have demonstrated that Ste23p is
capable of proteolyzing Aβ 1-40 and insulin B
chain (Fig. 3). While neither substrate represents a
likely physiological target of the fungal enzyme,
these observations are significant in that they
provide the first evidence that Ste23p exhibits
conserved specificity towards these established
substrates of mammalian M16A enzymes.
Reciprocal substrate specificity thus emerges as a
general property of fungal, mammalian, and
prokaryotic M16A enzymes, as we have
previously demonstrated that RnIDE and EcPtr can
proteolyze a Ste23p substrate − namely, the P2
precursor of the a-factor mating pheromone
(Alper, et al., 2006; Kim, et al., 2005). Our
observation that Ste23p can proteolyze both Aβ 140 and insulin B chain also indicates that substrate
recognition by Ste23p does not require the
presence of a farnesyl moiety, which is associated
with P2 a-factor, the only previously recognized
substrate of the yeast enzyme. Collectively, these
9
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optima exhibited by these enzymes may reflect
their having evolved to retain maximal activity
under a wide range of environmental conditions
for reasons that have yet to be elucidated. Despite
the similar biochemical and enzymatic properties
of RnIDE and Ste23p, whether Ste23p represents a
true insulinase remains open to interpretation.
While the yeast enzyme proteolyzes insulin B
chain (Fig. 3), we were unable able to document
cleavage of intact insulin by Ste23p, despite
measurable inhibition of Ste23p-mediated
proteolysis upon addition of insulin to the
fluorogenic assay mixture (Alper, Rowse, and
Schmidt, unpublished observations; Fig. 5).
Available evidence collectively indicates that
Ste23p is the most representative M16A enzyme
within S. cerevisiae. First, Ste23p shares higher
primary sequence homology to mammalian IDEs
and other M16A enzymes than does Axl1p (36%
vs. 18% identity to HsIDE, respectively; Table 3).
Second, like yeast-expressed RnIDE and EcPtr,
Ste23p is incapable of supporting certain Axl1pdependent functions within S. cerevisiae (i.e.,
maintenance of the haploid-specific axial budding
pattern and repression of haploid invasive growth
(Alper, et al., 2006; Cullen and Sprague, 2002;
Fujita, et al., 1994; Kim, et al., 2005). Third,
Ste23p has a relatively minor role in a-factor
processing,
despite
being
over-expressed
approximately 10-fold relative to Axl1p in MATa
haploids (Adames, et al., 1995; Alper, et al.,
2006). We now demonstrate that Ste23p is
expressed in diploid and MATα haploid yeast that
are incapable of producing a-factor (Fig. 7). This
observation is consistent with the broad tissue
expression of RnIDE mRNA transcripts
(Baumeister, et al., 1993) and may ultimately
imply a role for Ste23p in a conserved
housekeeping function that has yet to be
established.
The assignment of Ste23p as the most
representative yeast M16A ortholog supports a
continued focus on the biological properties of this
enzyme. A number of bioinformatic, genetic, and
biochemical studies have identified potential

interactors of Ste23p that may inform its
physiological relevance. Yet, to our knowledge,
none of these interactions have been thoroughly
investigated. Any future investigation of Ste23p
interactors must take into account two
observations. First, we have previously reported
that the STE23 stop codon was misannotated in the
original release of the yeast genome sequence
(Cherry, et al., 1998, Kim, 2005 #2765); a similar
conclusion was reached through comparative
analysis of related fungal genomes (Brachat, et al.,
2003). The net effect of this misannotation is a
predicted translation product with a shortened and
altered C-terminus. Second, we now report that
the initiator codon of Ste23p is also misannotated
(Fig. 6). Previously identified genetic interactors
of Ste23p must therefore be viewed with caution,
as the genetic constructs used to identify these
interactors have likely encoded forms of Ste23p
with non-physiological N-and C-termini.
In sum, this study provides evidence of
extensive enzymatic similarities among Ste23p,
RnIDE, and other M16A enzymes. These findings
support the conclusion that Ste23p represents a
suitable model for studies of the M16A subfamily
within S. cerevisiae. We thus anticipate that
continuing studies of Ste23p will serve to provide
significant insight into the biological properties of
this and other M16A enzymes.
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Table 1. Yeast and bacterial strains used in this study
Strain
IH1783

Genotypea
MATa trp1 leu2 ura3 his4 can1

Reference
(Michaelis and Herskowitz,
1988)
IH1784
MATα trp1 leu2 ura3 his4 can1
(Adames, et al., 1995)
IH1788
MATa/α trp1 leu2 ura3 his4 can1
(Michaelis and Herskowitz,
1988)
IH1793
MATα lys1
(Michaelis and Herskowitz,
1988)
Y272
MATa trp1 leu2 ura3 his4 can1 axl1::LEU2 ste23::LEU2
(Adames, et al., 1995)
DH5α
F-f80lacZD(lacZYA-argF) U169deoR recA1 endA1 Invitrogen Inc.
hsdR17(rk-mk+) phoA supE44 thi-1gyr A96 relA1 ton A
BL21(DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3)
Novagen Inc.
a

IH1783, IH1784, IH1788, and Y272 are isogenic.
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Table 2. Plasmids used in this study
Plasmid
p80
pET-30b(+)
pSM1569

Genotype
CEN URA3 STE23
pBR322 f1 KAN lacI pT7
AMP SRα-RnIDE

pRS316
pWS371
pWS375
pWS482
pWS759
pWS760
pWS761
pWS762
pWS763
pWS765
pWS769
pWS804
pWS908
pWS909

CEN URA3
CEN URA3 AXL1-2HAc
CEN URA3 STE23
CEN URA3 STE23-2HAc
CEN URA3 STE23-2HAc (∆-1467→-1)
CEN URA3 STE23-2HAc (∆-1467→-100)
CEN URA3 STE23-2HAc (∆-1467→-200)
CEN URA3 STE23-2HAc (∆-1467→-300)
CEN URA3 STE23-2HAc (∆-1467→-400)
CEN URA3 STE23-2HAc (∆-1467→+156)
pBR322 f1 KAN lacI pT7 6XHIS-STE23M53-E1027
pBR322 f1 KAN lacI pT7 6XHIS-RnIDEM42-L1019
CEN URA3 STE23M1A-2HAc
CEN URA3 STE23M53A-2HAc
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Reference
(Adames, et al., 1995)
Novagen Inc.
(Bondy, et al., 1994; Seta and
Roth, 1997)
(Sikorski and Hieter, 1989)
(Kim, et al., 2005)
(Kim, et al., 2005)
(Kim, et al., 2005)
This study
This study
This study
This study
This study
This study
This study
(Alper and Schmidt, 2009)
This study
This study
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Table 3. Conservation of sequence identity among M16A enzymes a,b

HsIDE
RnIDE
DmIDE
CeIDE
SlIDE
UmSte2
3p
SpSte23
p
Ste23p
EcPtr
Axl1p

HsIDE RnIDE DmIDE CeIDE
100
94
45
40
100
45
39
100
39
100

SlIDE UmSte2 SpSte23 Ste23p
3p
p
38
37
36
35
38
38
36
35
35
37
32
34
31
32
31
32
100
36
35
32
100
39
36
100
36
100

a

EcPtr
E
25
24
24
22
24
26
25
24
100

Axl1p
l1p
18
18
18
16
19
14
18
16
12
100

Percent sequence identity calculated using multiple global sequence alignment function of Clustal W
2.0.10.
b
Hs: Homo sapiens, Rn: Rattus norvegicus, Dm: Drosophila melanogaster, Ce: Caenorhabditis elegans,
Sl:Solanum lycopersicum, Um: Ustilago maydis, Sp: Schizosaccharomyces pombe, Ec: Eschericia coli.
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FIGURE LEGENDS
Figure 1. Sequence alignment of Ste23p and RnIDE
Ste23p and RnIDE protein sequences as annotated within the Saccharomyces Genome Database and
Swiss-Prot Database, respectively, were aligned using Clustal W 2.0.10. Conserved amino acids are
shaded black, and those considered similar are shaded grey. Closed and open arrowheads indicate the Nterminus of recombinant Ste23p and RnIDE isolated in this study and the position of the inserted 6xHis
affinity tag. The characteristic HxxEH metalloprotease motif, which is conserved among all M16A
enzymes, is indicated by a black bar. The two amino acids within 6xHis-RnIDEM42-L1019 that are different
from the annotated sequence are denoted in parentheses below the appropriate residue that they replace.
Figure 2. Purification recombinant Ste23p and RnIDE
Polyhistidine tagged Ste23p and RnIDE were expressed in E. coli from pET expressions vectors (pWS769
and pWS804, respectively) and isolated to near homogeneity. Two-fold serial dilutions of purified
6xHis-Ste23pM53-E1027 and 6xHis-RnIDEM42-L1019 were analyzed by SDS-PAGE and stained using
Coomassie™ Brilliant Blue R-250. The leftmost lane of each dilution series contains 7.5 µg of total
protein (lanes 1 and 5). The predicted molecular mass of 6xHis-Ste23pM53-E1027 is 113 kDa, and the
predicted mass of 6xHis-RnIDEM42-L1019 is 114 kDa.
Figure 3. Ste23p proteolyzes Aβ 1-40 and insulin B chain
The ability of Ste23p and RnIDE to proteolyze established IDE substrates Aβ 1-40 and insulin B chain
was evaluated by capillary electrophoresis (CE). Shown are chromatogram traces depicting UV
absorbance at 200 nM. A) Analysis of the individual components of the proteolytic reaction mixture.
Solutions contain 24 µM Aβ 1-40, 30 µM insulin B chain, 20 nM Ste23p, or 20 nM RnIDE in Proteolysis
Buffer, reflective of their initial concentrations within the proteolytic reaction mixture. B, C) Profile of
Aβ 1-40 (B) and insulin B chain (C) products produced by Ste23p at indicated timepoints. Peaks
contributed by substrates are denoted with arrowheads, and peaks contributed by the enzymatic
experimental component are denoted with asterisks. D, E) Profile of Aβ 1-40 (D) and insulin B chain (E)
produced by RnIDE after 4 hr incubation.
Figure 4. Comparative enzymatic properties of Ste23p and RnIDE
Proteolysis of the Abz-SEKKDNYIIKGV-nitroY-OH peptide by Ste23p (A, C, E) and RnIDE (B, D, F)
was evaluated over the indicated range of pH (A, B), salt concentration (C, D), and temperature (E, F)
using a continuous fluorescence assay. Proteolytic activity rates were determined from initial rates and
are presented as a percentage of the maximal enzyme activity observed within an experiment for each
variable evaluated. Reported values are the average of ≥ 3 experimental replicates. Error bars depict
standard deviation from the mean. Velocity vs. substrate concentration curves for Ste23p (G) and RnIDE
(H) were determined over a substrate concentration range of 3 – 172 µM. Km values were derived using
the nonlinear regression function of GraphPad Prism™ 4.0.
Figure 5. Sensitivity of Ste23p and RnIDE to various agents
Activities of Ste23p (black bars) and RnIDE (grey bars) were determined as described in Fig. 4 in the
presence of the indicated agents relative to untreated and DMSO (dimethyl sulfoxide)-treated controls.
Reported values are the average of three experimental replicates, and error bars indicate standard
deviation from the mean. EDTA (ethylenediaminetetraacetic acid), TPEN (N,N,N´-tetrakis-[2pyridylmethyl]ethylenediamine), 1,10-P (1,10-phenanthroline), 4,7-P (4,7-phenanthroline), NEM (Nethylmaleimide),
β-ME
(β-mercaptoethanol),
DTT
(dithiothreitol),
PMSF
(phenylmethylsulfonylfluoride), ATP (adenosine-5´-triphosphate), and GTP (guanosine-5´-triphosphate)
were added to a concentration of 1 mM within the proteolytic reaction mixture. Insulin was added to an
initial concentration of 0.8 mg/mL.
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Figure 6. Characterization of the translation start site of Ste23p
A) Schematic of the genomic DNA sequence that is 5´ to the predicted start codon of the STE23 open
reading frame within pWS482. Schematic is not drawn to scale. B) The predicted 5´ UTR of STE23 is
not required for expression of functional Ste23p. A set of plasmids bearing deletions of the 5´ UTR
contained within pWS482 (pWS759-763) and a plasmid lacking part of the STE23 ORF itself (pWS765)
were evaluated for their ability to promote yeast mating (top panel) and Ste23p expression (middle panel).
Yeast mating was evaluated by mixing MATα cells (IH1793) and M16A-deficient MATa cells (Y272)
carrying the indicated plasmid, followed by selection on diploid-selective media. Ste23p expression was
evaluated by immunoblotting. Equivalent percentage amounts (2%) of total cellular protein extracts were
separated by SDS-PAGE and transferred onto blots that were probed with anti-HA and anti-Act1p
antibodies as a loading control (middle and bottom panels, respectively). C) Expression of Ste23p
partially rescues the mating defect of an M16A-deficient yeast strain (Y272). Yeast mating assays and
analysis of Ste23p expression were performed as described in panel B; the panel order is preserved. WT
(IH1783) was transformed with an empty vector (pRS316), and Y272 was transformed with either
pRS316 or a plasmid encoding Ste23p-2HA (pWS482). D) The annotated start codon of STE23 is not
required for expression of functional Ste23p. Yeast mating assays and analysis of Ste23p expression
were performed as described in panel B using plasmid transformed Y272 cells, except that 4% of each
extract was evaluated; the panel order is preserved. Plasmids used were pWS908-909.
Figure 7. Ste23p is expressed in both haploid and diploid yeast
Plasmid-based expression of Ste23p (A) and Axl1p (B) was examined in MATa (IH1783), MATα
(IH1784), and diploid (IH1788) cell types using pWS482 and pWS371, respectively. The steady-state
levels of the indicated HA-tagged protein (top panel) and yeast actin (bottom panel) were detected by
immunoblotting as described in Fig. 6, except that 60% of the total cellular extract preparation was
evaluated in the instance of Axl1p samples due to its low abundance.
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